Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

LGI1 autoantibodies associated with cerebellar degeneration.

Steriade C, Day GS, Lee L, Murray BJ, Fritzler MJ, Keith J.

Neuropathol Appl Neurobiol. 2014 Aug;40(5):645-9. doi: 10.1111/nan.12132. No abstract available.

PMID:
24606111
[PubMed - indexed for MEDLINE]
2.

Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors.

Ohkawa T, Fukata Y, Yamasaki M, Miyazaki T, Yokoi N, Takashima H, Watanabe M, Watanabe O, Fukata M.

J Neurosci. 2013 Nov 13;33(46):18161-74. doi: 10.1523/JNEUROSCI.3506-13.2013.

PMID:
24227725
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma.

Iorio R, Damato V, Mirabella M, Vita MG, Hulsenboom E, Plantone D, Bizzarro A, Del Grande A, Sillevis Smitt PA.

J Neuroimmunol. 2013 Oct 15;263(1-2):155-8. doi: 10.1016/j.jneuroim.2013.07.015. Epub 2013 Aug 3.

PMID:
23958353
[PubMed - indexed for MEDLINE]
4.

[Paraneoplastic cerebellar degeneration].

Sakai K.

Brain Nerve. 2010 Apr;62(4):357-64. Review. Japanese.

PMID:
20420175
[PubMed - indexed for MEDLINE]
5.

Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, Pittock SJ.

JAMA Neurol. 2013 Feb;70(2):229-34. doi: 10.1001/jamaneurol.2013.592.

PMID:
23407760
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.

Brieva-Ruíz L, Diaz-Hurtado M, Matias-Guiu X, Márquez-Medina D, Tarragona J, Graus F.

Clin Neurol Neurosurg. 2008 Dec;110(10):1044-6. doi: 10.1016/j.clineuro.2008.06.016. Epub 2008 Aug 13.

PMID:
18701208
[PubMed - indexed for MEDLINE]
7.

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.

Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J.

Lancet Neurol. 2010 Aug;9(8):776-85. doi: 10.1016/S1474-4422(10)70137-X. Epub 2010 Jun 28.

PMID:
20580615
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration].

Miyatake T.

Rinsho Shinkeigaku. 1993 Dec;33(12):1291-3. Japanese.

PMID:
8174327
[PubMed - indexed for MEDLINE]
9.

Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome.

Clouston PD, Saper CB, Arbizu T, Johnston I, Lang B, Newsom-Davis J, Posner JB.

Neurology. 1992 Oct;42(10):1944-50. Review.

PMID:
1407577
[PubMed - indexed for MEDLINE]
10.

Antineural autoantibodies in patients with paraneoplastic cerebellar degeneration.

Tsukamoto T, Yamamoto H, Iwasaki Y, Yoshie O, Terunuma H, Suzuki H.

Arch Neurol. 1989 Nov;46(11):1225-9.

PMID:
2818258
[PubMed - indexed for MEDLINE]
11.

LGI1: from zebrafish to human epilepsy.

Cowell JK.

Prog Brain Res. 2014;213:159-79. doi: 10.1016/B978-0-444-63326-2.00009-0.

PMID:
25194489
[PubMed - in process]
12.

[Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].

Basić-Jukić N, Kes P, Basić-Kes V, Brunetta B.

Acta Med Croatica. 2004;58(1):63-6. Croatian.

PMID:
15125396
[PubMed - indexed for MEDLINE]
13.

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J.

Brain. 1997 Aug;120 ( Pt 8):1279-300.

PMID:
9278623
[PubMed - indexed for MEDLINE]
Free Article
14.

Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.

Greenlee JE, Clawson SA, Hill KE, Dechet CB, Carlson NG.

J Neurol Sci. 2010 Apr 15;291(1-2):74-8. doi: 10.1016/j.jns.2009.12.019. Epub 2010 Jan 20.

PMID:
20089262
[PubMed - indexed for MEDLINE]
15.

Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration.

Dropcho EJ, Chen YT, Posner JB, Old LJ.

Proc Natl Acad Sci U S A. 1987 Jul;84(13):4552-6.

PMID:
3474619
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Arrested glutamatergic synapse development in human partial epilepsy.

Anderson MP.

Epilepsy Curr. 2010 Nov;10(6):153-8. doi: 10.1111/j.1535-7511.2010.01386.x.

PMID:
21157544
[PubMed]
Free PMC Article
17.

VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy.

Shin YW, Lee ST, Shin JW, Moon J, Lim JA, Byun JI, Kim TJ, Lee KJ, Kim YS, Park KI, Jung KH, Lee SK, Chu K.

J Neuroimmunol. 2013 Dec 15;265(1-2):75-81. doi: 10.1016/j.jneuroim.2013.10.005. Epub 2013 Oct 17.

PMID:
24176648
[PubMed - indexed for MEDLINE]
18.

Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Shams'ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, Vecht C, Sillevis Smitt P.

Brain. 2003 Jun;126(Pt 6):1409-18.

PMID:
12764061
[PubMed - indexed for MEDLINE]
Free Article
19.

Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies.

Coesmans M, Smitt PA, Linden DJ, Shigemoto R, Hirano T, Yamakawa Y, van Alphen AM, Luo C, van der Geest JN, Kros JM, Gaillard CA, Frens MA, de Zeeuw CI.

Ann Neurol. 2003 Mar;53(3):325-36.

PMID:
12601700
[PubMed - indexed for MEDLINE]
20.

Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization.

Sakai K, Shirakawa T, Kitagawa Y, Li Y, Hirose G.

J Autoimmun. 2001 Dec;17(4):297-302.

PMID:
11771954
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk